May 21, 2026 • 7:00am EDT Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
May 12, 2026 • 7:00am EDT Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder